Hippocrates, Galen, Pliny the Elder and others believed willow bark could ease aches and pains and reduce fevers. It has long been used in Europe and China for the attempted treatment of these conditions. This remedy is also mentioned in texts from ancient Egypt, Sumer, and Assyria. The first “clinical trial” was reported by Reverend Edward Stone, a vicar from Chipping Norton in Oxfordshire, England, in 1763 with a successful treatment of malarial fever with the willow bark. . . .
The active extract of the bark, called salicin, after the Latin name Salix, was isolated to its crystalline form in 1828 by Henri Leroux, a French pharmacist, and Raffaele Piria, an Italian chemist, who then succeeded in separating out the acid in its pure state. Salicylic acid, like aspirin, is a chemical derivative of salicin.
“Dr. Anthony Fauci: No clash with Trump on malaria drug for coronavirus” (Tom Howell, Jr., The Washington Times, 3-22-20). Excerpts:
Anthony Fauci, the main scientist in the U.S. coronavirus response, says combining a malaria drug with certain antibiotics shows “anecdotal” promise for COVID-19 patients and that his push for more proof doesn’t mean he is clashing with President Trump.
“I think there’s this issue of trying to separate the two of us. There isn’t fundamentally a difference there,” Dr. Fauci, the director of the told CBS’s “Face the Nation” on Sunday. “He’s coming at it from a hope-layperson standpoint. I’m coming at it from a scientific standpoint.” . . .
“I’m not disagreeing with the fact, anecdotally, they might work,” Dr. Fauci told CBS. “But my job is to prove definitely from a scientific standpoint that they do work.”
“Governor Andrew Cuomo Coronavirus Briefing Transcript March 23″ (Rev.com, 3-23-20; [link] ). Excerpt:
I also asked for the FDA to expedite the approval of an experimental drug that we are working on here in the state of New York, which I’ll tell you more about in a moment. The President also did that. The FDA gave the New York State Department of Health approval to use on a compassionate care basis a drug that we think has real possibility. On the drug therapy, Tuesday we’re going to start the hydroxy chloroquine with the Zithromax. That’s the drug combination that the President has been talking about. The FDA approved New York State Department of Health to proceed with an experimental drug, again on a compassionate care basis.
“Dr. Stephen Smith on effectiveness of hydroxychloroquine: ‘I think this is the beginning of the end of the pandemic'” (Talia Kaplan, Fox News, 4-2-20). Excerpts:
Dr. Stephen Smith, founder of The Smith Center for Infectious Diseases and Urban Health, said on “The Ingraham Angle” on Wednesday night that he is optimistic about the use of antimalarial medications and antibiotics to treat COVID-19 patients, calling it “a game-changer.”
“I think this is the beginning of the end of the pandemic. I’m very serious,” Smith, an infectious disease specialist, told host Laura Ingraham. . . .
Smith, who is treating 72 COVID-19 patients, said that he has been treating “everybody with hydroxychloroquine and azithromycin [an antibiotic]. We’ve been doing so for a while.”
He pointed out that not a single COVID-19 patient of his that has been on the hydroxychloroquine and azithromycin regimen for five days or more has had to be intubated.
“The chance of that occurring by chance, according to my sons Leon and Hunter who did some stats for me, are .000-something,” he said, adding that “it’s ridiculously low.”
Smith explained that “intubation means actually putting a tube down into your trachea and then you’re placed on the ventilator for respiratory support.”
“Hydroxychloroquine rated ‘most effective’ coronavirus treatment, poll of doctors finds” (Natalie, O’Neill, New York Post, 4-2-20). Excerpt:
Of the 2,171 physicians surveyed, 37 percent [i.e., 803 doctors] rated hydroxychloroquine the “most effective therapy” for combating the potentially deadly illness, according to the results released Thursday. . . .
The medicine was most widely used in Spain, where 72 percent of physicians said they had prescribed it.
“After mocking Trump for promoting hydroxychloroquine, journalists acknowledge it might treat coronavirus” (Gregg Re, Fox News, 4-3-20)
“French researcher Dr. Didier Raoult has now treated 1000 coronavirus patient with 99.3% success rate” (Tech Startups, revised 4-6-20). Excerpt:
In a follow-up study, which has a larger sample size of 80 COVID-19 patients, the team found a clinical improvement in all but one 86 year-old patient who died, and one 74-year old patient still in intensive care unit. The team also found that, by administering hydroxychloroquine combined with azithromycin, they were able to observe an improvement in all cases, except in one patient who arrived with an advanced form, who was over the age of 86, and in whom the evolution was irreversible, according to a new paper published today in IHU Méditerranée Infection.
We now have new updates. Tonight, Dr. Oz said during an interview that Dr. Raoult is about to publish the results of his new study. Dr. Oz announced that Dr. Didier Raoult has now treated 1000 coronavirus patient with 99.3% success rate. Of the 1000 patients treatments, 20 patients went to the ICU and 7 patients died. Dr. Raoult said the side effects were trivial things like rash etc.
White House economic adviser Peter Navarro said President Trump was correct to talk about “the possibility” that the long-used anti-malaria drug hydroxychloroquine can treat some symptoms of the coronavirus. . . .
“You may find this interesting,” he told the CNN host [John Berman]. “In the city that you live in, in New York, in the New York health and hospitals system, virtually every patient now that comes in presenting COVID-19 symptoms is given a cycle of hydroxychloroquine, and when I discussed this last night with Mitch Katz, who is the head of that system, I asked him, are you doing that because the federal government is telling you or because you think it may work? And he said quite clearly that it may work.”
Over the past three weeks, we’ve been sharing with you the great work Dr. Zelenko, a board-certified family practitioner in New York, has been doing in the treatment of COVID-19 patients in New York. In our last piece, Dr. Vladimir Zelenko treated 700 coronavirus patients treated with 99.9% success rate using Hydroxychloroquine, 1 outpatient died after not following protocol. In the meantime, more doctors are seeing success with hydroxychloroquine and Zinc Sulphate in treating coronavirus patients, according to one report from ABC News. 12 French doctors have also filed a petition calling on French Prime Minister and Minister of Health to urgently make hydroxychloroquine available in all French hospital pharmacies
Today, we have new and encouraging updates from Dr. Zelenko. In a one-hour video, Dr. Zelenko provides a detailed medical explanation about why his cocktail of Hydroxychloroquine Sulfate, Zinc and Azithromycin (not Z-Pak) works, and why the three-drug combination are really needed in killing coronavirus.
“Reports Are In: Malaria Drug Saves Lives in Coronavirus Crisis, Doctors and Patients Say” (Tyler O’Neil, PJ Media, 4-7-20).
Reports are in: Hydroxychloroquine is saving lives and President Donald Trump deserves praise for advocating the malaria drug as a potential cure for COVID-19, the disease caused by the coronavirus. A small study in France laid the groundwork for using the drug in treatment. Doctors and patients across America have reported positive results, despite constant naysaying from left-leaning media outlets. . . .
Dr. Anthony Cardillo, the CEO of Mend Urgent Care in Los Angeles, said he is witnessing “significant success” in prescribing hydroxychloroquine to coronavirus patients.
“Every patient I’ve prescribed it to has been very, very ill and within eight to twelve hours, they were basically symptom-free,” Cardillo told ABC News.